Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-17-031581
Filing Date
2017-06-07
Accepted
2017-06-07 17:39:08
Documents
1
Period of Report
2016-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 v467960_form3.html 3  
1 FORM 3 v467960_form3.xml 3 3511
  Complete submission text file 0001144204-17-031581.txt   5262
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Reporting) CIK: 0001429260 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-55668 | Film No.: 17898174
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Issuer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 0312
SIC: 2834 Pharmaceutical Preparations